Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MY008211A in PNH with Residual Anemia
NCT06932471Phase 3Recruiting
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd.
- Start
- Aug 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of MY-008 in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Wuhan Createrna Science and Technology Co., Ltd.. Started Aug 2024; status: recruiting.
02
Drugs
MY-008
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT06932471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06932471.